Management

• Corporate Management
• Board of Directors
• Board of Scientific Advisors

Corporate Management:

Thomas D. Ingolia, Ph.D.
Chairman

After earning his doctorate in Biochemistry at U.C./Berkeley, Ingolia spent 13 years at Eli Lilly, beginning as a research scientist and moving rapidly up the management ranks to CEO of Sphinx Pharmaceuticals--a technology acquisition that Ingolia targeted, evaluated and managed for Lilly. From there, Ingolia moved into biotech, with senior executive positions at Ontogeny and Microbia in Cambridge, and Prolexys in Salt Lake City. Ingolia joins Medisyn directly from Prolexys, where he was CEO.

David Land
President

David is a senior executive with diverse experience in general management, sales, marketing, customer care, IT and operations. He has an extensive international background working with Fortune 50 and start-up companies alike. Before Medisyn, David was Vice President with Jostens, an $800 million achievement recognition and celebration events company. David held executive roles with Lenox, Inc. in operations, IT and sales after beginning his career in a variety of systems engineering positions. He earned a diploma (equivalent to bachelor's degree) from Seminaire Adventiste du Saleve in France following studies in mathematics at Loma Linda University, California and studies in mathematics, physics and chemistry at Bournemouth Junior College in England.

Board of Directors:

Thomas D. Ingolia, Ph.D. - Chairman
former CEO, Prolexys, former senior manager, Eli Lilly and Company

Henry A. Cousineau III  - Director
President, Entropy Solutions, Inc.

Mark Kroll, Ph.D. - Director
former Senior Vice President and Chief Technology Officer, St. Jude Medical, Inc.

David Land - Director
President, Medisyn Technologies

Jack Meyer  - Director
former CEO of Urologix, Fiberoptic Sensor Technology, Carelink

Steven Pederson - Director
Partner, Sherpa Partners LLC

Ian Troup - Director
former COO, Upsher-Smith

Board of Scientific Advisors:

James E. Brewer
Brewer Consulting

Arkadiusz Dudek, M.D., Ph.D.
Assistant Professor of Medicine, University of Minnesota
Director of the Clinical Trial Office, Hematology, Oncology and Transplantation (HOT) Division, University of Minnesota Medical School

Dr. Jorge Gálvez
Senior Professor of Pharmacy, University of Valencia
Ph.D. Chemistry
Molecular Topology & Physical Chemistry

Dr. Kim Janda
Professor, Department of Chemistry
The Scripps Research Institute

Dr. Christopher A. Lipinski
Senior Research Fellow, Pfizer Global R&D (retired)

Thomas R. Parr, Jr., Ph.D.
Chief Scientific Officer, Targanta Therapeutics

Dr. George Wilcox
Professor of Pharmacology, University of Minnesota Medical School
Ph.D. Bioengineering
Pharmacology & Pain, Bioengineering